- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-3-3-mer
 - Ligands
 - 16 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 - 36 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 NAG.19: 4 residues within 4Å:- Chain A: N.709, I.1130, G.1131
 - Chain B: D.796
 
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain A: E.1072, K.1073, N.1074
 
Ligand excluded by PLIPNAG.21: 1 residues within 4Å:- Chain A: N.657
 
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain A: N.616, T.618
 
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain A: N.331, Q.580
 
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain A: N.603
 
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain A: E.340, N.343, S.371
 
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Chain A: N.61
 
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain A: N.149, S.151, W.152
 
Ligand excluded by PLIPNAG.28: 5 residues within 4Å:- Chain A: E.132, N.164, N.165
 - Chain C: Y.351, T.470
 
Ligand excluded by PLIPNAG.29: 4 residues within 4Å:- Chain A: N.280, E.281, N.282
 - Chain C: K.558
 
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain A: N.17, N.137
 - Chain D: T.28
 
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain B: E.1072, N.1074
 
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain B: N.616, E.619
 
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain B: N.657
 
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain B: N.603
 
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain B: N.709
 - Chain C: K.795
 
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain B: F.59, N.61
 
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain B: N.149, S.151, W.152
 
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain A: Y.351
 - Chain B: E.132, N.164, N.165
 
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain B: N.331, P.579, Q.580
 
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain B: N.17
 - Chain H: Q.1, L.27, T.28
 
Ligand excluded by PLIPNAG.41: 4 residues within 4Å:- Chain A: K.558
 - Chain B: N.280, E.281, N.282
 
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain B: G.339, N.343, S.371
 
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain C: N.709, G.1131
 
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain C: E.1072, K.1073, N.1074
 
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain C: N.343, S.371, A.372
 
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain C: H.655, N.657
 
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain C: N.616, T.618
 
Ligand excluded by PLIPNAG.48: 1 residues within 4Å:- Chain C: N.603
 
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain C: N.331, Q.580, T.581
 
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain C: F.59, N.61
 
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain C: N.149, S.151, W.152
 
Ligand excluded by PLIPNAG.52: 3 residues within 4Å:- Chain C: E.132, N.164, N.165
 
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain C: N.280, E.281, N.282
 
Ligand excluded by PLIPNAG.54: 3 residues within 4Å:- Chain C: N.17
 - Chain F: Q.1, T.28
 
Ligand excluded by PLIP- Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Cerutti, G. et al., Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite. Cell Host Microbe (2021)
          


 - Release Date
 - 2021-03-24
 - Peptides
 - Spike glycoprotein: ABC
5-24 heavy chain: DFH
5-24 light chain: EGI - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
GH
IE
LG
JI
K 
- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-3-3-mer
 - Ligands
 - 16 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 - 36 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Cerutti, G. et al., Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite. Cell Host Microbe (2021)
          


 - Release Date
 - 2021-03-24
 - Peptides
 - Spike glycoprotein: ABC
5-24 heavy chain: DFH
5-24 light chain: EGI - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
GH
IE
LG
JI
K